Cognitive Impairment and Blood Pressure: Quo usque tandem abutere patientia nostra?

Hypertension

Volumn 44, Issue 5, 2004, Pages 612-613

  Staessen, Jan A ^a   Birkenhäger, Willem H ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; DIHYDROPYRIDINE; INDAPAMIDE; NIMODIPINE; NITRENDIPINE; PERINDOPRIL; THIAZIDE DIURETIC AGENT;

ALZHEIMER DISEASE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; DEMENTIA; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EDITORIAL; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR;

ALZHEIMER DISEASE; BLOOD PRESSURE; COGNITION; HUMANS; HYPERTENSION;

EID: 7244226197     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000145864.95630.20     Document Type: Editorial

References (15)

1. Elias ME, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993;138:353-364.
2. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment. A 20-year follow-up of 999 men. Hypertension. 1998;31:780-786.
3. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
4. Elias PK, Elias MF, Robbins MA, Budge MM. Blood-pressure related cognitive decline: does age make a difference? Hypertension. 2004;44:631-636.
5. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F. Progression of cerebral white matter lesions: 6-year results of the Austrian stroke prevention study. Lancet. 2003;361:2046-2048.
6. van Dijk EJ, Breteler MMB, Schmidt R, Berger K, Nilsson LG, Oudkerk M, Pajak A, de Ridder M, Dufouil C, Fuhrer R, Giampoli S, Launer LJ, Hofman A, for the CASCADE Consortium. The association between blood pressure, hypertension and cerebral white matter lesions: the CASCADE study. Hypertension. 2004;44:625-630.
7. Dufouil C, de Kersaint-Gilly A, Besançon V, Levy C, Auffray E, Brunnereau L, Alpérovitch A, Tzourio C. Longitudinal study of blood pressure and white matter hyperintensities. The EVA MRI cohort. Neurology. 2001;56:921-926.
8. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
9. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ. 1996;312:801-805.
10. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, for the SCOPE Study Group. The study on cognition and prognosis in the elderly (SCOPE). Principal results of a randomised double-blind intervention trial. J Hypertens. 2003;21:875-886.
11. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with prior stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
12. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhäger WH, for the Syst-Eur Investigators. The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) Study [erratum published in The Arch Intern Med 2003, volume 163, January 27, p 241]. Arch Intern Med. 2002;162:2046-2052.
13. Zipfel GJ, Lee JM, Choi DW. Reducing calcium overload in the ischemic brain. N Engl J Med. 1999;341:1543-1544.
14. Morich FJ, Bieber F, Lewis JM, Kaiser L, Cutler NR, Escobar JI, Willmer J, Petersen RC, Reisberg B, The North Am Nimodipine Study Group. Nimodipine in the treatment of probable Alzheimer's disease: result of two multicentre trials. Clin Drug Invest. 1996;11:185-195.
15. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337-1342.